Khushbu Mahajan1, Vineet Relhan2, Aditi Kochhar Relhan3, Vijay Kumar Garg2. 1. Department of Dermatology, North Delhi Municipal Corporation Medical College, Hindu Rao Hospital, New Delhi, India. 2. Maulana Azad Medical College, New Delhi, India. E-mail: vineetrelhan@gmail.com. 3. South Delhi MCD Hospital, New Delhi, India.
Sir,We are grateful to the authors for such a comprehensive reading of our article and making enlightening observations regarding the same.[1] As already pointed out, clustering and seasonal variation remains a controversial point in pityriasis rosea (PR) as different studies have conflicting observations and so a definite opinion cannot be drawn.The recent classification of PR variants by Drago et al. is indeed the most comprehensive classification available till date and provides the most elaborate and exhaustive view on most commonly seen clinical variants with ready to take away points which will help differentiate between different manifestations of PR. However, since this classification was published at a later stage than our article, the same could not be incorporated in our review article.PR being a very common condition with evolving pathogenesis, varied presentations, and therapeutic options; there are a lot of studies and review articles already published or underway dealing with different aspects of it. Thus, with the limitations of word limit, despite an extensive literature search, not all of it could be incorporated under one review article. The aim of our review was to cover all important headings with special emphasis on etiopathogenesis and management of difficult aspects, which had so far being not dealt with in detail.The articles cited are definitely a useful source of further and more elaborate information, and we recommend their reading in special cases as in when dealing with vaccine induced and PR-like eruptions.